Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases

Rheumatology International

Volumn 29, Issue 11, 2009, Pages 1327-1330

  Aoki, Yoko ^a   Iwamoto, Masahiro ^a   Kamata, Yasuyuki ^a   Nagashima, Takao ^a   Yoshio, Taku ^a   Okazaki, Hitoaki ^a   Minota, Seiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Collagen vascular disease; PCP; Pneumocystis jirovecii; Pneumocystis pneumonia

Indexed keywords

CHOLINESTERASE; COTRIMOXAZOLE; GLUCOCORTICOID; PENTAMIDINE; PREDNISOLONE; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; LUNG ALVEOLUS OXYGEN TENSION; MALE; MEDICAL RECORD REVIEW; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; VASCULAR DISEASE;

ADULT; AGED; CHOLINESTERASES; COLLAGEN DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; SERUM ALBUMIN; VASCULAR DISEASES;

EID: 69049100039     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0857-z     Document Type: Article

References (12)

1. SM Arend FP Kroon JW van't Wout 1995 Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993 Arch Intern Med 155 2436 2441 10.1001/archinte.155.22.2436
2. DA Russian SJ Levine 2001 Pneumocystis carinii pneumonia in patients without HIV infection Am J Med Sci 321 56 65 10.1097/00000441-200101000-00009
3. A Yasuoka N Tachikawa K Shimada, et al. 1996 (1 → 3) β-d-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia Clin Diagn Lab Immunol 3 197 199
4. K Saito S Nakayamada K Nakano, et al. 2004 Detection of Pneumocystis carinii by DNA amplication in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases Rheumatology 43 479 485 10.1093/rheumatology/keh071
5. AH Limper KP Offord TF Smith, et al. 1989 Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS Am Rev Respir Dis 140 1204 1209
6. MM Ward F Donald 1999 Pneumocystis carinii pneumonia in patients with connective tissue diseases Arthritis Rheum 42 780 789 10.1002/1529-0131(199904) 42:4<780::AID-ANR23>3.0.CO;2-M
7. B Godeau V Coutant-Perronne DLT Huong, et al. 1994 Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases J Rheumatol 21 246 251
8. N Iikuni M Kitahama S Ohta, et al. 2006 Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease Mod Rheumatol 16 282 288 10.1007/s10165-006-0502-6
9. S Ewig T Bauer C Schneider, et al. 1995 Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients Eur Respir J 8 1548 1553 10.1183/09031936.95.08030392
10. A Iwama M Yoshida A Miwa, et al. 1993 Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy Eur J Haematol 51 156 160
11. T Yoshida K Tsushima A Tsuchiya, et al. 2005 Risk factors for hospital-acquired bacteremia Intern Med 11 1157 1162 10.2169/internalmedicine. 44.1157
12. T Sato S Inokuma R Maezawa, et al. 2005 Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases Mod Rheumatol 15 191 197 10.1007/s10165-005-0395-9